NEXENTIS TECHNOLOGIES INC. Earnings Per Share (Basic)
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Earnings Per Share (Basic) of -$13.66 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for the quarter ending 2026-06-30 was -$13.66.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for the quarter ending 2026-03-31 was -$10.74.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.52.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.45.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for fiscal 2025 was -$3.54.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for fiscal 2024 was -$27.74.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for fiscal 2023 was -$5.43, a 150.05% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic for fiscal 2022 was $10.85.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.66 10-Q · filed 2026-08-13 | -$24.79 10-Q · filed 2026-08-13 | -$12.69 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$13.26 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$10.74 10-Q · filed 2026-05-14 | -$3.46 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$3.65 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$9.12 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | $0.52 derived: net income ÷ weighted average shares · filed 2026-03-31 | $1.00 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.40 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$3.54 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $0.45 10-Q · filed 2025-11-13 | -$7.81 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$7.65 10-Q · filed 2025-11-13 | -$18.58 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$44.26 10-Q · filed 2026-08-13 | -$0.18 10-Q · filed 2025-08-14 | -$67.74 10-Q · filed 2026-08-13 | -$0.28 10-Q · filed 2025-08-14 | -$43.54 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$57.12 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2025-03-31 | -$18.00 10-Q · filed 2026-05-14 | -$0.07 10-Q · filed 2025-05-15 | -$13.31 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$26.24 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$5.67 derived: net income ÷ weighted average shares · filed 2026-05-14 | |||
| 2024-12-31 | -$4.30 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$14.97 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$3.41 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$27.74 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$14.27 10-Q · filed 2025-11-13 | -$0.39 10-Q · filed 2024-11-14 | -$1.71 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$28.45 10-Q · filed 2025-11-13 | -$0.94 10-Q · filed 2024-11-14 | -$2.68 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||
| 2024-06-30 | -$0.23 10-Q · filed 2025-08-14 | -$0.49 10-Q · filed 2025-08-14 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$2.40 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||||
| 2024-03-31 | -$0.26 10-Q · filed 2025-05-15 | -$1.06 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$2.42 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$3.16 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$1.00 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$2.67 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$3.52 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$5.43 10-K · filed 2025-03-31 | $5.43 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$1.78 10-Q · filed 2024-11-14 | -$2.61 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.69 10-Q · filed 2024-11-14 | -$6.61 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$0.69 10-Q · filed 2024-08-14 | -$0.10 10-Q · filed 2023-08-14 | -$2.80 10-Q · filed 2024-08-14 | -$0.42 10-Q · filed 2023-08-14 | -$4.75 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$7.52 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||
| 2023-03-31 | -$2.46 10-Q · filed 2024-05-15 | -$0.37 10-Q · filed 2023-05-15 | -$4.50 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$7.53 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$5.10 derived: net income ÷ weighted average shares · filed 2024-05-15 | |||
| 2022-12-31 | -$2.03 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$5.07 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$3.22 derived: net income ÷ weighted average shares · filed 2024-04-01 | $10.85 10-K · filed 2024-04-01 | -$1.64 10-K · filed 2023-03-27 | |||
| 2022-09-30 | -$3.15 10-Q · filed 2023-11-14 | -$0.48 10-Q · filed 2022-11-14 | -$1.76 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$9.12 10-Q · filed 2023-11-14 | -$1.39 10-Q · filed 2022-11-14 | -$2.61 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2022-06-30 | -$0.44 10-Q · filed 2023-08-14 | -$0.91 10-Q · filed 2023-08-14 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.47 10-Q · filed 2023-05-15 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$1.49 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$2.14 derived: net income ÷ weighted average shares · filed 2023-05-15 | ||||
| 2021-12-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$1.67 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$2.06 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | -$0.46 10-Q · filed 2022-11-14 | -$1.12 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.49 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.69 10-Q · filed 2022-08-15 | -$1.05 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$0.31 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | -$1.05 derived: net income ÷ weighted average shares · filed 2022-03-31 | |||||||
| 2019-12-31 | -$1.38 derived: net income ÷ weighted average shares · filed 2021-03-29 | |||||||
| 2018-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |